264 related articles for article (PubMed ID: 32117196)
1. KSHV: Immune Modulation and Immunotherapy.
Broussard G; Damania B
Front Immunol; 2019; 10():3084. PubMed ID: 32117196
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
Alomari N; Totonchy J
Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
[TBL] [Abstract][Full Text] [Related]
4. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
6. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
7. Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.
Qin Z; Peruzzi F; Reiss K; Dai L
Viruses; 2014 Nov; 6(11):4571-80. PubMed ID: 25421888
[TBL] [Abstract][Full Text] [Related]
8. The Interplay between KSHV Infection and DNA-Sensing Pathways.
Han C; Gui C; Dong S; Lan K
Viruses; 2024 May; 16(5):. PubMed ID: 38793630
[TBL] [Abstract][Full Text] [Related]
9. Contribution of viral mimics of cellular genes to KSHV infection and disease.
Sakakibara S; Tosato G
Viruses; 2014 Sep; 6(9):3472-86. PubMed ID: 25243371
[TBL] [Abstract][Full Text] [Related]
10. Biology of Kaposi's sarcoma-associated herpesvirus.
Bryan BA; Dyson OF; McCubrey JA; Akula SM
Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
[TBL] [Abstract][Full Text] [Related]
11. The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases.
Pringle ES; Wertman J; Melong N; Coombs AJ; Young AL; O'Leary D; Veinotte C; Robinson CA; Ha MN; Dellaire G; Druley TE; McCormick C; Berman JN
Viruses; 2019 Dec; 12(1):. PubMed ID: 31861850
[TBL] [Abstract][Full Text] [Related]
12. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
Giffin L; West JA; Damania B
mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
[TBL] [Abstract][Full Text] [Related]
14. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
15. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
19. Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.
Ngalamika O; Munsaka S
J Immunol Res; 2020; 2020():8852221. PubMed ID: 33294468
[TBL] [Abstract][Full Text] [Related]
20. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.
He M; Cheng F; da Silva SR; Tan B; Sorel O; Gruffaz M; Li T; Gao SJ
Cancer Treat Res; 2019; 177():23-62. PubMed ID: 30523620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
